Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-05-092495
Filing Date
2005-05-02
Accepted
2005-05-02 17:12:24
Documents
4
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2004 d10ka.htm 10-K/A 190035
2 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9067
3 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 8854
4 GRAPHIC g17685graph.jpg GRAPHIC 50925
  Complete submission text file 0001193125-05-092495.txt   279755
Mailing Address 2950 WILDERNESS PLACE BOULDER CO 80301
Business Address 2950 WILDERNESS PLACE BOULDER CO 80301 3034496500
SIRNA THERAPEUTICS INC (Filer) CIK: 0000892112 (see all company filings)

EIN.: 341697351 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-27914 | Film No.: 05791702
SIC: 2834 Pharmaceutical Preparations